Other studies demonstrated that the presence of CTLA-4 and PD-1 on T cells may modulate the immune response and protect the vital organ from an excessive inflammatory environment in severe COVID-19 patients (51, 58). This evidence concerns the gene PDCD1 and COVID-19.